Open for feedback
Proposed extension of the abbreviated procedure for new medicine applications and section 24(5)(a) notifications
This consultation is aimed at pharmaceutical companies seeking to submit abbreviated applications to Medsafe for regulatory approval of new medicine products or changed medicine notifications. Medsafe is seeking your feedback on changes to these guidelines: Guideline on the Regulation of Therapeutic Products in New Zealand: New Medicine Applications Guideline on the Regulation of Therapeutic Products in New Zealand: Changed Medicine Notifications and...
Ngā Paerewa Health and Disability Services Standard consultation 2026
Ngā Paerewa Health and Disability Services Standard 2021 (Ngā Paerewa) came into effect in February 2022. Under the requirements of the Health and Disability Services (Safety) Act 2001 (the Act), a regular review of the Standard is required. Consultation The Ministry of Health invites organisations and individuals to give their feedback on the Standard and participate in a short consultation. The feedback received will help to determine whether any changes are needed to the...
Verification Pathway for New Medicine Applications
This consultation is primarily aimed at pharmaceutical companies seeking to submit applications to Medsafe for new medicines for consent by verification. Consent by verification is the application pathway that enables expedited approval of medicines in New Zealand. This relies on assessment and approval by two recognised overseas regulatory authorities. The verification approval process was enabled by the Medicines Amendment Act 2025, and is described in section 22A to 22F of the Medicines...
Closed for feedback
Cervical screening: Provider and practitioner survey
The National Cervical Screening Programme (NCSP) was established in 1990 following recommendations from the Cartwright Inquiry (1988) to deliver a national cervical screening programme and aims to...
Experiences with cervical screening
A Parliamentary Review Committee has been established to independently review the performance of the National Cervical Screening Programme and make recommendations to support its improvement. ...
Proposed amendments to the designated pharmacist prescriber specified prescription medicines list
The Ministry of Health – Manatū Hauora (the Ministry) invites submissions on the proposed addition of 21 prescription medicines and one medicine class (vaccines) to the specified prescription...
Proposed amendments to the designated registered nurse prescriber specified prescription medicines list
The Ministry of Health – Manatū Hauora (the Ministry) invites submissions on the proposed addition of 190 prescription medicines and four medicine classes to the designated registered nurse...
Safe Areas - Survey
The Ministry of Health | Manatū Hauora (the Ministry) is conducting its annual survey to understand provider experiences and observations following the establishment of a Safe Area around their...
Clozapine: Proposed changes to blood monitoring and prescribing requirements - consultation questions for consumers and families
This Medsafe consultation seeks your feedback on proposed changes to the blood monitoring for clozapine. We are running this consultation on behalf of the companies that distribute...